Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Mann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical and Experimental Dermatology|December 23, 2021
A multicentre qualitative study of patient skin surgery experience during the COVID-19 pandemic in the UKIqra Ashraf, Yasmin Nikookam, Albert Hong, et al.
The British Journal of Dermatology|August 17, 2022
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational studyAnusuya Kawsar, Charlotte Edwards, Pooja Patel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 16, 2019
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitorsAine O'Reilly, Peta Hughes, Jasmine Mann, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical and Experimental Dermatology|December 23, 2021
A multicentre qualitative study of patient skin surgery experience during the COVID-19 pandemic in the UKIqra Ashraf, Yasmin Nikookam, Albert Hong, et al.
The British Journal of Dermatology|August 17, 2022
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational studyAnusuya Kawsar, Charlotte Edwards, Pooja Patel, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 16, 2019
An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitorsAine O'Reilly, Peta Hughes, Jasmine Mann, et al.
Pageof 1